Last reviewed · How we verify

NCT04025242

Objective Assessment of Adherence to Inhalers by COPD Patients

Completed Last updated 23 July 2019
What this trial tests

trial in COPD in 244 participants. Completed in 1 April 2016.

Timeline
1 February 2012
Primary endpoint
28 February 2016
1 April 2016

Quick facts

Lead sponsorBeaumont Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment244
Start date1 February 2012
Primary completion28 February 2016
Estimated completion1 April 2016

Conditions studied

Sponsor

Beaumont Hospital

Who can join

18 and older, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rationale: Objective adherence to inhaled therapy by patients with chronic obstructive pulmonary disease (COPD) has not been reported. Objectives: To objectively quantify adherence to preventer Diskus inhaler therapy by patients with COPD with an electronic audio recording device (INCA). Methods: This was a prospective observational study. On discharge from hospital patients were given a salmeterol/fluticasone inhaler with an INCA device attached. Analysis of this audio quantified the frequency and proficiency of inhaler use.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

Other Beaumont Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04025242.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing